Eosinophilia-Myalgia Syndrome [myalgický syndrom s eozinofilií]
- Terms
-
eozinofilní myalgický syndrom
eozinofilní myalgický syndrom související s L-tryptofanem
syndrom myalgický s eozinofilií
-
Eosinophilia-Myalgia Syndrome, L-Tryptophan-Related
L-Tryptophan-Related Eosinophilia-Myalgia Syndrome
Syndrome, Eosinophilia-Myalgia, L-Tryptophan-Related
A complex systemic syndrome with inflammatory and autoimmune components that affect the skin, fascia, muscle, nerve, blood vessels, lung, and heart. Diagnostic features generally include EOSINOPHILIA, myalgia severe enough to limit usual activities of daily living, and the absence of coexisting infectious, autoimmune or other conditions that may induce eosinophilia. Biopsy of affected tissue reveals a microangiopathy associated with diffuse inflammation involving connective tissue. (From Spitzer et al., J Rheumatol Suppl 1996 Oct;46:73-9; Blackburn WD, Semin Arthritis Rheum 1997 Jun;26(6):788-93)
- DUI
- D016603 MeSH Browser
- CUI
- M0025320
- Previous indexing
- Eosinophilia/chemically induced (1989-1990); Muscular Diseases/chemically induced (1990); Tryptophan/adverse effects (1989-1990)
- History note
- 92
- Public note
- 92
Allowable subheadings
- BL
- blood 0
- CF
- cerebrospinal fluid 0
- CI
- chemically induced 0
- CL
- classification 0
- CO
- complications 0
- CN
- congenital 0
- DI
- diagnosis 0
- DG
- diagnostic imaging 0
- DH
- diet therapy 0
- DT
- drug therapy 1
- EC
- economics 0
- EM
- embryology 0
- EN
- enzymology 0
- EP
- epidemiology 0
- EH
- ethnology 0
- ET
- etiology 1
- GE
- genetics 0
- HI
- history 0
- IM
- immunology 0
- ME
- metabolism 0
- MI
- microbiology 0
- MO
- mortality 0
- NU
- nursing 0
- PS
- parasitology 0
- PA
- pathology 0
- PP
- physiopathology 0
- PC
- prevention & control 0
- PX
- psychology 0
- RT
- radiotherapy 0
- RH
- rehabilitation 0
- SU
- surgery 0
- TH
- therapy 0
- UR
- urine 0
- VE
- veterinary 0
- VI
- virology 0